EH - GME BLUE EH and VBIV among premarket gainers
MediciNova (MNOV) +87% on BARDA partnership for Ibudilast development.Cemtrex (CETX) +85%.Koss Corporation (KOSS) +50%.Obalon Therapeutics (OBLN) +34%.Enveric Biosciences (ENVB) +39% on agreement to acquire exclusive license for novel molecules from Diverse Biotech.MoneyGram International (MGI) +26%.Exela Technologies (XELA) +35%.Express (EXPR) +22% on Q4 results.Atossa Therapeutics (ATOS) +22%.Artelo Biosciences (ARTL) +21%.Super League Gaming (SLGG) +20%.Build-A-Bear Workshop (BBW) +19% on Q4 results.ChromaDex Corporation (CDXC) +19% on Walmart Tru Niagen distribution tie up.LAIX (LAIX) +15%.Lion Group Holding (LGHL) +15%.GameStop (GME) +14%.Affimed N.V. (AFMD) +13% on continuation of REDIRECT study of AFM13 in T-cell cancer.Lexaria Bioscience (LEXX) +13%.Ontrak (OTRK) +12%.EHang Holdings Limited (EH) +12%.The9 Limited (NCTY) +11%.bluebird bio (BLUE) +11% after providing updated findings from reported case of Acute Myeloid Leukemia.Caladrius Biosciences (CLBS) +11%.Huttig Building Products (HBP) +10%.VBI Vaccines (VBIV) +10% on partnership to develop VBI’s eVLP vaccine candidates against SARS-CoV-2
For further details see:
GME, BLUE, EH and VBIV among premarket gainers